Holden Comprehensive Cancer Center researcher Yousef Zakharia, MD, has presented promising data at a national meeting about combining a new investigational immunotherapy drug with an FDA-approved immunotherapy drug to treat patients with advanced melanoma.

Evidence is growing that adding high-dose, intravenous vitamin C in combination with standard chemotherapy and radiation treatment is a safe, relatively inexpensive approach that may improve outcomes for patients with a wide range of cancers.

Heart disease. Diabetes. Alzheimer’s. Most people reading this know someone affected by one of these serious medical conditions. They take a huge toll on populations across the globe, leading to millions of deaths each year and billions of dollars in health care costs.

Meet Ling Yang, PhD, assistant professor of anatomy and cell biology.

Medical students graduating from the University of Iowa Carver College of Medicine gathered in the atrium of the college’s Medical Education and Research Facility (MERF) this morning, filled with anticipation as they waited to see where they would spend their residency.

Meet Huxing Cui, PhD, assistant professor of pharmacology.

Meet Kimberly Staffey, MD

A new study in rats suggests that nicotinamide riboside (NR), a form of vitamin B3, may be useful for treating or preventing nerve pain (neuropathy) caused by chemotherapy drugs.